T-B+ severe combined immunodeficiency due to JAK3 deficiency: genes and variants
Explore variant evidence for T-B+ severe combined immunodeficiency due to JAK3 deficiency across 3 analyzed proteins (JAK3, PTPRC, IL7R). Linked ClinVar records include 22 pathogenic or likely pathogenic variants, 247 variants of uncertain significance and 9 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to T-B+ severe combined immunodeficiency due to JAK3 deficiency
JAK3: Tyrosine-protein kinase JAK3
It carries signals from cytokine receptors using the common gamma chain and is essential for T-cell and NK-cell development. Biallelic loss-of-function variants cause severe combined immunodeficiency, while activating somatic variants occur in selected leukemias and lymphomas.
22 ClinVar pathogenic / likely pathogenic and 256 uncertain variants in JAK3 have source records linked to T-B+ severe combined immunodeficiency due to JAK3 deficiency. Association strength is not clinical gene validity.
PTPRC: Receptor-type tyrosine-protein phosphatase C
It controls phosphorylation of Src-family kinases and is essential for effective antigen-receptor signaling in nearly all nucleated blood cells. Biallelic loss-of-function variants can cause severe combined immunodeficiency.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PTPRC have source records linked to T-B+ severe combined immunodeficiency due to JAK3 deficiency. Association strength is not clinical gene validity.
IL7R: Interleukin-7 receptor subunit alpha
It transmits survival and developmental signals required for T-cell and lymphoid homeostasis. Biallelic loss-of-function variants cause T-cell-negative, B-cell-positive severe combined immunodeficiency, while somatic activating alterations occur in acute lymphoblastic leukemia.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in IL7R have source records linked to T-B+ severe combined immunodeficiency due to JAK3 deficiency. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to T-B+ severe combined immunodeficiency due to JAK3 deficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| JAK3 C193Y | 193 | FERM | Pathogenic / likely pathogenic (★★★) |
| JAK3 R582W | 582 | Protein kinase 1 | Pathogenic / likely pathogenic (★★★) |
| JAK3 R403H | 403 | SH2 | Pathogenic / likely pathogenic (★★★) |
| JAK3 R103C | 103 | FERM | Pathogenic / likely pathogenic (★★) |
| JAK3 R103H | 103 | FERM | Pathogenic / likely pathogenic (★★) |
| JAK3 D144V | 144 | FERM | Pathogenic / likely pathogenic (★★) |
| JAK3 G589S | 589 | Protein kinase 1 | Pathogenic / likely pathogenic (★★) |
| JAK3 R775H | 775 | Protein kinase 1 | Pathogenic / likely pathogenic (★★) |
| JAK3 R651W | 651 | Protein kinase 1 | Pathogenic / likely pathogenic (★★) |
| JAK3 T714M | 714 | Protein kinase 1 | Pathogenic / likely pathogenic (★★) |
| JAK3 R402H | 402 | SH2 | Pathogenic / likely pathogenic (★★) |
| JAK3 G528D | 528 | Protein kinase 1 | Pathogenic / likely pathogenic (★) |
| JAK3 R350W | 350 | FERM | Pathogenic / likely pathogenic (★) |
| JAK3 G397V | 397 | SH2 | Pathogenic / likely pathogenic (★) |
| JAK3 I430T | 430 | SH2 | Pathogenic / likely pathogenic (★) |
| JAK3 E1019K | 1019 | Protein kinase 2 | Pathogenic / likely pathogenic (★) |
| JAK3 L369P | 369 | Pathogenic / likely pathogenic (★) | |
| JAK3 V146G | 146 | FERM | Pathogenic / likely pathogenic (★) |
| JAK3 D784N | 784 | Pathogenic / likely pathogenic (★) | |
| JAK3 Y100C | 100 | FERM | Pathogenic / likely pathogenic |
| JAK3 V599G | 599 | Protein kinase 1 | Pathogenic / likely pathogenic |
| JAK3 W709R | 709 | Protein kinase 1 | Pathogenic / likely pathogenic |
Which prediction tools work for T-B+ severe combined immunodeficiency due to JAK3 deficiency
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CADD: 99 out of 100
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 95 out of 100
- AlphaMissense: 94 out of 100
- PolyPhen-2: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 93 out of 100
- MetaSVM: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 89 out of 100
- MutPred: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 69 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 26 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to T-B+ severe combined immunodeficiency due to JAK3 deficiency
- Severe combined immunodeficiency, also linked to IL7R and JAK3
- Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive, also linked to JAK3
- Crohn disease, also linked to JAK3
- Essential thrombocythemia, also linked to JAK3
- Hypothyroidism, also linked to IL7R
- Multiple sclerosis, also linked to IL7R
Frequently asked questions
Which genes have records linked to T-B+ severe combined immunodeficiency due to JAK3 deficiency?
This view contains 3 analyzed proteins: JAK3, PTPRC, IL7R. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 22 pathogenic or likely pathogenic variants, 247 variants of uncertain significance and 9 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 515 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center